RxDoctor Payments Data

Anna Mapes

Nurse Practitioner · Benzonia, MINPI 1053910703

Payments from drug & device makers

$3,121in general payments, 2019–2025

Across 131 payments — averaging $23.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$961
  • AstraZeneca$500
  • Novo Nordisk$342
  • Axsome Therapeutics, Inc.$231
  • Astellas Pharma US Inc$212
  • GSK$178
  • plus $698 from 14 others

What the payments were for

  • Food & beverage$3,03197%
  • Education$903%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,121 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide25$37,640
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$19,645
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$19,592
OzempicSemaglutide11$10,008
VyvanseLisdexamfetamine Dimesylate12$4,686
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$3,364
Atorvastatin Calcium143$2,250
Fluticasone Propionate18$1,734
Albuterol Sulfate HfaAlbuterol Sulfate39$1,448
Levothyroxine Sodium101$1,382
Losartan Potassium63$1,066
Lisinopril103$989
Omeprazole51$878
Rosuvastatin Calcium40$800
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine17$738

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$178$19,64516 claims
AstraZenecaBreztri Aerosphere$500$19,59216 claims
Novo NordiskOzempic$342$10,00811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Benzonia

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →